[인포스탁데일리=김현욱AI 앵커]
Whether to resume trading of Osstem Implant, which has been suspended from stock trading due to embezzlement of 200 billion won, will be decided today.
The Korea Exchange determines the eligibility of Osstem Implant to be relisted.
Earlier this year, Osstem Implant experienced a substantive review of listing eligibility due to embezzlement of 200 billion won by an employee in charge of money management.
It was originally announced that it would decide whether to relist on the 24th of last month, but it is known that the decision was delayed due to high social interest.
Some raised the possibility of delisting due to the fact that an internal control system was not implemented once morest the embezzlement of 200 billion won by employees and the controversy over bad accounting.
If the Korea Exchange gives an ‘inappropriate’ audit opinion, Osstem Implant will immediately suspend stock trading.
A legal official said, “The key in this case will be to prove the company’s opaque accounting management system and the accounting firm’s poor auditing.”
However, Osstem Implant’s minority shareholders amounted to regarding 20,000 as of the end of 2020, so if stock trading is suspended, it can cause great damage.
Osstem Implant is emphasizing its position that it will make efforts to resume trading as soon as possible.
Osstem Implant’s minority shareholders are pursuing legal action, such as filing a claim for damages once morest Mr. Lee and the company, who are accused of embezzlement.
Kim Hyun-wook AI anchor webmaster@infostock.co.kr
© Infostock Daily Unauthorized reproduction and redistribution prohibited
